tradingkey.logo
tradingkey.logo
Search

Trinity Biotech PLC

TRIB
Add to Watchlist
11.670USD
-0.130-1.10%
Close 08-14 16:00ETQuotes delayed by 15 min
7.52MMarket Cap
LossP/E TTM

TRIB Financials

See Trinity Biotech PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Trinity Biotech PLC Earnings Date

Latest Release
Apr 30, 2026
EPS / Forecast
--/--
Revenue / Forecast
43.78M/--
Period
FY2025 Earnings
Revenue(YoY)
43.78M
-28.87%
EPS(YoY)
-1.81K
-11.78%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
Financial Indicators
EPS
2.73%-840.60
39.94%-8.26
55.14%-9.61
-10.78%-14.42
73.24%-28.81
89.55%-13.75
81.74%-21.41
-242.09%-13.02
-1529.92%-107.64
-2141.31%-131.52
-1541.25%-117.30
69.53%-3.81
---6.60
---5.87
---7.15
---12.49
----
----
----
----
----
----
----
Revenue
--11.07M
-5.54%14.31M
----
----
----
3.24%15.15M
13.99%15.84M
-0.84%14.70M
-14.61%13.43M
-6.54%14.68M
-9.85%13.90M
-5.40%14.83M
104.02%15.73M
-28.63%15.70M
-40.35%15.42M
-38.76%15.68M
-76.47%7.71M
-31.27%22.00M
61.28%25.84M
20.86%25.59M
53.70%32.77M
30.17%32.01M
-28.77%16.02M
Net Profit
---17.48M
-7.90%-5.13M
----
----
----
29.19%-4.76M
-12.84%-6.76M
42.90%-3.32M
45.42%-5.50M
24.86%-6.72M
38.31%-5.99M
52.69%-5.81M
-696.76%-10.08M
-777.14%-8.95M
-1139.59%-9.71M
-866.48%-12.28M
87.38%-1.27M
-81.97%1.32M
46.63%-783.00K
172.10%1.60M
57.02%-10.02M
29200.00%7.33M
72.86%-1.47M
Net Margin
-52.77%-157.84%
-14.23%-35.88%
-29.17%-55.09%
-415.14%-116.21%
-152.34%-103.32%
31.40%-31.41%
67.69%-42.65%
46.94%-22.56%
38.16%-40.94%
28.01%-45.79%
-101.13%-132.00%
49.01%-42.52%
---66.21%
---63.60%
---65.63%
---83.38%
----
----
----
----
----
----
----
Gross Margin
14.47%35.21%
29.01%45.19%
17.68%42.59%
-32.88%25.20%
-9.57%30.76%
20.13%35.03%
0.00%36.19%
-0.07%37.55%
-0.49%34.01%
1291.94%29.16%
-0.03%36.19%
-1.52%37.58%
--34.18%
--2.10%
--36.20%
--38.16%
----
----
----
----
----
----
----
Debt to assets ratio
34.50%131.21%
17.51%113.01%
14.21%112.98%
14.10%108.20%
-14.01%97.55%
-8.73%96.17%
5.77%98.92%
12.36%94.83%
44.72%113.45%
78.13%105.37%
38.95%93.52%
17.11%84.40%
--78.39%
--59.16%
--67.31%
--72.06%
----
----
----
----
----
----
----
Revenue
--11.07M
-5.54%14.31M
----
----
----
3.24%15.15M
13.99%15.84M
-0.84%14.70M
-14.61%13.43M
-6.54%14.68M
-9.85%13.90M
-5.40%14.83M
104.02%15.73M
-28.63%15.70M
-40.35%15.42M
-38.76%15.68M
-76.47%7.71M
-31.27%22.00M
61.28%25.84M
20.86%25.59M
53.70%32.77M
30.17%32.01M
-28.77%16.02M
Operating profit
---1.30M
80.10%-509.00K
----
----
----
43.16%-2.56M
10.68%-3.61M
22.40%-3.04M
31.96%-3.48M
22.98%-4.50M
-203.31%-4.04M
-222.29%-3.92M
-316.42%-5.12M
-312.63%-5.84M
-121.17%-1.33M
-139.51%-1.22M
-118.69%-1.23M
-69.75%2.75M
1154.69%6.29M
81.81%3.08M
279.20%6.58M
581.55%9.09M
-58.42%501.00K
Net Profit
---17.48M
-7.90%-5.13M
----
----
----
29.19%-4.76M
-12.84%-6.76M
42.90%-3.32M
45.42%-5.50M
24.86%-6.72M
38.31%-5.99M
52.69%-5.81M
-696.76%-10.08M
-777.14%-8.95M
-1139.59%-9.71M
-866.48%-12.28M
87.38%-1.27M
-81.97%1.32M
46.63%-783.00K
172.10%1.60M
57.02%-10.02M
29200.00%7.33M
72.86%-1.47M
Current assets
--35.90M
-22.93%35.52M
-28.24%33.00M
----
----
5.14%46.08M
-13.10%45.98M
-20.98%46.04M
-16.34%39.04M
-12.05%43.83M
-7.55%52.92M
-0.02%58.26M
-35.80%46.67M
-36.31%49.83M
-29.74%57.24M
-33.49%58.27M
-12.74%72.69M
8.12%78.25M
24.01%81.46M
29.85%87.61M
16.68%83.30M
-10.77%72.37M
----
Total current liabilities
--141.21M
22.96%34.49M
22.32%31.52M
----
----
120.24%28.05M
74.59%25.77M
41.29%22.82M
-13.29%15.04M
-13.51%12.74M
6.33%14.76M
1.34%16.15M
-82.75%17.34M
-85.68%14.73M
-86.86%13.88M
-49.64%15.94M
271.39%100.49M
345.43%102.88M
364.27%105.62M
43.43%31.65M
39.12%27.06M
-10.83%23.10M
----
Total assets
--105.17M
6.43%103.71M
5.59%99.63M
----
----
53.22%97.45M
31.07%94.36M
-0.93%90.31M
-35.47%59.44M
-35.04%63.60M
-32.81%71.99M
-14.08%91.16M
-22.53%92.10M
-20.27%97.89M
-14.10%107.14M
-21.98%106.10M
-8.82%118.89M
-9.77%122.78M
-3.11%124.72M
5.31%135.98M
-0.51%130.40M
-21.46%136.07M
----
Total liabilities
--177.15M
27.98%158.43M
20.54%149.17M
----
----
52.67%123.79M
48.44%123.75M
15.74%113.16M
-11.56%83.38M
-11.15%81.08M
-8.71%83.37M
-13.00%97.78M
-20.92%94.28M
-25.18%91.26M
-27.07%91.32M
-17.43%112.38M
-10.11%119.21M
-5.45%121.97M
-3.26%125.22M
6.04%136.11M
4.95%132.62M
-3.96%129.00M
----
Total equity
---71.98M
-107.71%-54.72M
-68.50%-49.54M
----
----
-50.64%-26.34M
-158.35%-29.40M
-245.38%-22.86M
-1000.60%-23.95M
-363.64%-17.49M
-171.94%-11.38M
-5.30%-6.62M
-582.13%-2.18M
718.89%6.63M
3289.31%15.82M
-4848.82%-6.29M
85.62%-319.00K
-88.54%810.00K
30.34%-496.00K
-116.54%-127.00K
-147.08%-2.22M
-81.84%7.07M
----
Net operating income
---1.55M
101.01%59.00K
----
----
----
10.81%-5.82M
51.30%-3.08M
10.09%-4.82M
-249.30%-966.00K
-544.66%-6.52M
-62.02%-6.33M
-17.53%-5.36M
-73.08%647.00K
-165.67%-1.01M
-397.45%-3.91M
-175.03%-4.56M
-77.06%2.40M
-78.08%1.54M
-204.67%-785.00K
304.99%6.08M
285.91%10.48M
51.70%7.03M
223.97%750.00K
Net investment
---804.00K
52.61%-1.47M
----
----
----
-250.11%-3.10M
-111.37%-3.17M
-950.64%-13.96M
21.64%-891.00K
33.08%-886.00K
1647.03%27.86M
22.51%-1.33M
51.76%-1.14M
33.27%-1.32M
16.39%-1.80M
21.90%-1.71M
30.22%-2.36M
-4.42%-1.98M
0.42%-2.15M
20.32%-2.20M
-79.39%-3.38M
49.68%-1.90M
29.77%-2.16M
Net financing
--6.14M
-81.36%1.20M
----
----
----
1227.67%6.44M
151.08%5.90M
390.13%20.85M
-153.42%-555.00K
16.52%-571.00K
-283.25%-11.54M
143.40%4.25M
86.85%-219.00K
2.29%-684.00K
975.00%6.30M
-1022.01%-9.80M
-815.02%-1.67M
11.39%-700.00K
-119.26%-720.00K
155.89%1.06M
118.49%233.00K
-4.22%-790.00K
593.27%3.74M

FAQs

What is the total revenue of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its total revenue reached 43.78M, with a year-on-year change of 61.55M.

What are the total assets of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its total assets of Trinity Biotech PLC were 105.17M, with a year-on-year change of 1.82.

What are the total liabilities of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its total liabilities of Trinity Biotech PLC were 177.15M, with a year-on-year change of 27.93.

What is the total equity of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its total equity of Trinity Biotech PLC was -71.98M, with a year-on-year change of -104.60.

What is the net operating income of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its net operating income of Trinity Biotech PLC was -11.42M, with a year-on-year change of 42.22.

What is the net investment of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its net investment of Trinity Biotech PLC was -6.22M, with a year-on-year change of 72.91.

What is the net financing of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its net financing of Trinity Biotech PLC was 12.36M, with a year-on-year change of -57.10.

What is the Earnings Per Share (EPS) of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -1810.80, with a year-on-year change of -11.78.

What is the net income of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its net income was -37.38M, with a year-on-year change of -17.58.

What is the net margin of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its net profit margin was -85.36, with a year-on-year change of -68.33.

What is the gross margin of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its gross margin was 38.57, with a year-on-year change of 10.72.

What is the debt-to-asset ratio of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its debt-to-asset ratio was 131.21, with a year-on-year change of 34.50.

What is the Return on Assets (ROA) of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its Return on Assets (ROA) was -35.86, with a year-on-year change of 6.53.

What is the operating profit of Trinity Biotech PLC?

According to Trinity Biotech PLC's FY2025 earnings report, its operating profit was -11.42M, with a year-on-year change of 42.22.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.